Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis

Clinical Biochemistry

Volumn 34, Issue 4, 2001, Pages 303-307

  Maass, Nicolai ^a   Hojo, Takashi ^b   Rösel, Frank ^a   Ikeda, Tadashi ^b   Jonat, Walter ^a   Nagasaki, Koichi ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Maspin; Metastasis; RT PCR; Tumor suppressor

Indexed keywords

MASPIN; SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER INHIBITION; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOWN REGULATION; EVALUATION; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; PLEURA METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034964699     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00220-X     Document Type: Article

References (30)

1. Urokinase-plasminogen activator, a new, and independent prognostic marker in breast cancer
2. Structure and mechanism of action of serpins
3. The serpin superfamily of proteinase inhibitors: Structure, function and regulation
4. Membrane proteases: Role in tissue remodelling and tumor invasion
5. Immunochistochemical localizations of the plasminogen activator inhibitor-1 in breast cancer
6. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: Prognostic relevance and target for therapy
7. Both cytosols and detergent extract of breast cancer tissue are suited to evaluate the prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1
8. Production, purification, and characterization of recombinant maspin proteins
9. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells
10. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast
11. Transactivation through Ets and Ap1 transcriptional sites determines the expression of the tumor-suppressing gene maspin
12. Transkriptionelle Regulierung von Protease-Inhibitor Maspin in Brustepithel-u
13. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells
14. p53 regulates the expression of tumor suppressor gene maspin
15. Maspin is an angiogenesis inhibitor
16. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene
17. Histological grading and prognosis in breast cancer
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Epigenetic silencing of maspin gene expression in human breast cancer
20. Angiogenesis as a predictor of clinical outcome in cancer patients
21. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma
22. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
23. Pathological prognostic factors in breast cancer. IV. Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma
24. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer
25. The long term prognostic significance of c-erbB-2 in primary breast cancer
26. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
27. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
28. Use of reverse-transecriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: Comparison with immunocytochemistry